GlobeNewswire
-
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
24/06/2026 -
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
24/06/2026 -
Helus Pharma™ Announces US$50 Million Underwritten Offering
24/06/2026 -
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
24/06/2026 -
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
24/06/2026 -
FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing
24/06/2026 -
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24/06/2026 -
uniQure Announces Pricing of Upsized $225 Million Public Offering
24/06/2026 -
Glass House Brands Provides Notice of Warrant Acceleration
24/06/2026 -
SELECTIS HEALTH, INC. ENTERS INTO AGREEMENT TO BE ACQUIRED BY BLACK PEARL
23/06/2026 -
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
23/06/2026 -
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
23/06/2026 -
DBV Technologies intégrera l’Indice Euronext Tech Leaders
23/06/2026 -
'Possibilities' Premieres June 27, Reimagining Accessible Filmmaking Through Collaboration Between Blind, Low-Vision, and Sighted Creatives
23/06/2026 -
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
23/06/2026 -
Nyxoah to Host Investor Day in New York on July 8, 2026
23/06/2026 -
Nyxoah Organisera une Journée Investisseurs à New York le 8 juillet 2026
23/06/2026 -
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
23/06/2026 -
Acquisition of Own Shares
23/06/2026
Pages